JAMA Network

JAMA Oncology Author Interviews

Health EN ↓ 129 episodes

Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of...

Author

JAMA Network

Category

Health

Podcast website

jamanetwork.com

Latest episode

Nov 26, 2025

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors 27.04.2017

Interview with Arvind Dasari, MD, author of Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

Birth Outcomes Among Adolescent and Young Adult Cancer Survivors 23.03.2017

Interview with Hazel B. Nichols, PhD, author of Birth Outcomes Among Adolescent and Young Adult Cancer Survivors

Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Trials 16.02.2017

Interview with Ethan M. Basch, MD, MSc, author of Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials

Delayed Adjuvant Chemotherapy After Lung Cancer Surgery 05.01.2017

Interview with Daniel Joseph. Boffa, MD, author of Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer Surgery

Global Burden of Cancer 2015 03.12.2016

Interview with Christina Fitzmaurice, MD, MPH, author of Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study  

Comparison of Vaginal Testosterone Cream or Vaginal Ring 10.11.2016

Interview with Michelle E. Melisko, MD, author of Vaginal Testosterone Cream vs Estradiol Vaginal Ring for Vaginal Dryness or Decreased Libido in Women Receiving Aromatase Inhibitors for Early-Stage Breast Cancer: A Randomized Clinical Trial  

Association Between Androgen Deprivation Therapy and Risk of Dementia 13.10.2016

Interview with Kevin T. Nead, MD, MPhil, author of Association Between Androgen Deprivation Therapy and Risk of Dementia

Adjuvant Endocrine Therapy and Risk of Contralateral Breast Cancer 06.10.2016

Interview with Gretchen L. Gierach, PhD, author of Association of Adjuvant Tamoxifen and Aromatase Inhibitor Therapy With Contralateral Breast Cancer Risk Among US Women With Breast Cancer in a General Community Setting

Prognostic Factors for Local Control in Breast Cancer With Boost vs No Boost 08.09.2016

Interview with Conny Vrieling, MD PhD, author of Prognostic Factors For Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial: A Randomized Clinical Trial

ESR1 Mutations in Metastatic Breast Cancer 11.08.2016

Interview with Sarat Chandarlapaty, MD, PhD, author of Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer: A Secondary Analysis of the BOLERO-2 Clinical Trial

Outcomes for Biomarker-Based Treatment Strategies in Refractory Malignant Neoplasms 06.06.2016

Interview with Razelle Kurzrock, MD, author of Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms: A Meta-analysis

Physiologic Frailty in Hematopoietic Cell Transplantation Patients 02.06.2016

Interview with Smita Bhatia, MD, MPH, author of Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor Study

Lifestyle Associations With US Cancer Incidence and Mortality 19.05.2016

Interview with Mingyang Song, MD, ScD, author of Preventable Incidence and Mortality of Carcinoma Associated With Lifestyle Factors Among Whites in the United States

Neratinib vs Trastuzumab for Untreated Metastatic ERBB2-Positive Breast Cancer 14.04.2016

Interview with Ahmad Awada, MD, PhD, author of Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial , and Mark D. Pegram, MD, author of Neratinib in ERBB2-Positive Brain Metastases

Prostate-Specific Antigen Screening and Selective Treatment 24.03.2016

Interview with Ruth Etzioni, PhD, author of Economic Analysis of Prostate-Specific Antigen Screening and Selective Treatment Strategies , and Andrew J. Vickers, PhD, author of Does Prostate-Specific Antigen Screening Do More Good Than Harm? Depends on How You Do It

Effect of Long-term Use of Aspirin on the Risk for Cancer 03.03.2016

Interview with Andrew T. Chan, MD, MPH, author of Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer

BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer 11.02.2016

Interview with Ann H. Partridge, MD, MPH, author of BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer

Molecular Profiling in Pediatric Tumors 28.01.2016

Interview with Katherine A. Janeway, MD, MSc, author of Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) Study , and D. Williams Parsons, MD, PhD, author of Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors

Delayed Initiation of Chemotherapy and Breast Cancer 10.12.2015

Interview with Mariana Chavez-MacGregor, MD, MSc, author of Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer , and Richard J. Bleicher, MD, author of Time to Surgery and Breast Cancer Survival in the United States

Erlotinib and the Risk of Oral Cancer 05.11.2015

Interview with William N. William Jr, MD, and Scott M. Lippman, MD, author of Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial

Breast Tumor Characteristics and Biennial vs Annual Mammography 20.10.2015

Interview with Diana L. Miglioretti, PhD, author of Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status

Agent Orange Exposure and Monoclonal Gammopathy 03.09.2015

Interview with Ola Landgren, MD, PhD, author of Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort Study , and Nikhil C. Munshi, MD, author of Association of Agent Orange With Plasma Cell Disorder: Further Evidence

Differences in the Acute Toxic Effects of Breast Radiotherapy 06.08.2015

Interview with Reshma Jagsi, MD, DPhil, author of Differences in the Acute Toxic Effects of Breast Radiotherapy by Fractionation Schedule: Comparative Analysis of Physician-Assessed and Patient-Reported Outcomes in a Large Multicenter Cohort, and Benjamin D. Smith, MD, author of Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Random...

Trends in Advance Care Planning in Patients With Cancer 09.07.2015

Interview with Amol K. Narang, MD, author of Trends in Advance Care Planning in Patients With Cancer: Results From a National Longitudinal Survey, and Michael J. Fisch, MD, author of Advance Directives: Sometimes Necessary But Rarely Sufficient

Obesity and Postmenopausal Invasive Breast Cancer Risk 11.06.2015

Interview with Marian L. Neuhouser, PhD, RD, author of Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials, and Clifford Hudis, MD, author of Obesity and Breast Cancer: Narrowing the Focus

Listen to the JAMA Oncology Author Interviews podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.